Harrow Health, Inc.HROWNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, modest growth trend.
Left:
||||
Year-over-year research & development expense growth
Latest
83.85%
Near historical average
Average (9y)
87.57%
Historical baseline
Range
High:359.35%
Low:-72.48%
CAGR
+8.5%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 83.85% |
| 2023 | 118.10% |
| 2022 | -72.48% |
| 2021 | 359.35% |
| 2020 | 15.84% |
| 2019 | 152.48% |
| 2018 | 99.76% |
| 2017 | -44.11% |
| 2016 | 122.59% |
| 2015 | 40.29% |